移植与非移植肝细胞癌患者特征和生存率
Brian I Carr1, Volkan Ince2, Harika Gozukara Bag3
1Liver Transplant Institute, Inonu University Faculty of Medicine, 44280, Malatya, Turkiye.
概括
肝移植为肝细胞癌 (HCC) 患者提供了很好的生存率. 然而,由于晚期瘤,只有三分之一的HCC患者有资格接受移植,这突显了治疗可获得性的差距.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 手术瘤学手术瘤学
- 移植手术 移植手术
背景情况:
- 肝细胞癌 (HCC) 的存活率在肝移植后是很好的 (>75%的5年存活率).
- 在一般人群中,HCC总体存活率仍然很低 (<30%的5年存活率).
- 移植结果和一般的HCC存活率之间存在显著的差异.
研究的目的:
- 调查接受肝移植的HCC患者比例较低的原因.
- 分析影响HCC患者移植资格的因素.
- 为了比较移植和非移植的HCC队列之间的结果.
主要方法:
- 在5年内对新的HCC患者进行前性评估.
- 通过CAT扫描评估基线瘤特征 (大小,攻击性).
- 记录血液学,肝功能和生存数据.
主要成果:
- 在628名HCC患者中,30.4%接受了肝移植,61.1%接受了非手术治疗.
- 移植患者的HCC较小,不那么具有攻击性,平均存活时间更长 (43.06个月).
- 非手术治疗的患者有更大,更具攻击性的HCC和更短的平均存活时间 (31.51个月).
结论:
- 肝移植显著改善了符合条件的HCC患者的生存率.
- 未来的努力应集中在HCC预防,早期检测和扩大移植资格上.
- 瘤在呈现时的进展是HCC肝脏移植的关键障碍.
相关概念视频
Kidney Transplant I: Introduction
64
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
64
Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524


